Cargando…

A Retrospective Study of Dexamethasone, Remdesivir, and Baricitinib in Severe COVID-19

PURPOSE: RECOVERY, ACTT-1, and ACTT-2 trials have demonstrated that utilization of dexamethasone, remdesivir, or a combination of remdesivir with baricitinib leads to mortality benefit and faster time to recovery, respectively. However, no studies have investigated the benefit of triple therapy of d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ngo, Dallis Q., Hamid, Kewan, Rana, Haris, Cardinale, Maria, Frenia, Douglas, Ghani, Nabil, Redel, Henry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279094/ https://www.ncbi.nlm.nih.gov/pubmed/35845297 http://dx.doi.org/10.1155/2022/9209618

Ejemplares similares

The Utility of Point-of-Care Ultrasound for Post-Bronchoscopy Pneumothorax Evaluation
por: Ngo, Dallis Q, et al.
Publicado: (2021)

Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19
por: Izumo, Takehiro, et al.
Publicado: (2021)

Efficacy of the combination of baricitinib, remdesivir, and dexamethasone in hypoxic adults with COVID-19: A retrospective study
por: Yasuda, Yuto, et al.
Publicado: (2022)

Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis
por: Pérez-Alba, Eduardo, et al.
Publicado: (2021)

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
por: Kalil, Andre C., et al.
Publicado: (2020)

COVID-19-Associated Pulmonary Aspergillosis in a Patient Treated With Remdesivir, Dexamethasone, and Baricitinib: A Case Report
por: Shimada, Ayako, et al.
Publicado: (2022)

Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA
Publicado: (2021)

507. Impact of Baricitinib on Outcomes in Patients Treated with Remdesivir and Dexamethasone for SARS-CoV-2 Pneumonia: A Retrospective Cohort Study
por: Dea, Lauren, et al.
Publicado: (2021)

Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection
por: Vitiello, Antonio, et al.
Publicado: (2021)

Use of Baricitinib in Combination With Remdesivir and Steroid in COVID-19 Treatment: A Multicenter Retrospective Study
por: So, Jessica M, et al.
Publicado: (2021)

REMDESIVIR PLUS DEXAMETHASONE VS TOCILIZUMAB OR BARICITINIB SUPPLEMENTATION INITIATED INSIDE 48 HOURS OF INDEX COVID-19 HOSPITALIZATION IN ICU PATIENTS
por: WILLIAMS, STEPHANIE N, et al.
Publicado: (2022)

Safety and Efficacy of Combination Therapy of Remdesivir, Baricitinib, and High-dose Steroids in Patients Hospitalized with Moderate to Severe COVID-19
por: Nagasawa, Ryo, et al.
Publicado: (2023)

Combination therapy with predicted body weight-based dexamethasone, remdesivir, and baricitinib in patients with COVID-19 pneumonia: A single-center retrospective cohort study during 5th wave in Japan
por: Hirasawa, Yasutaka, et al.
Publicado: (2023)

THE EFFICACY OF REMDESIVIR WITH DEXAMETHASONE VS. DEXAMETHASONE ALONE IN ADULTS HOSPITALIZED WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: AL-MISTAREHI, ABDEL-HAMEED, et al.
Publicado: (2022)

Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study
por: Gressens, Simon B., et al.
Publicado: (2022)

Fewer COVID‐19 Neurological Complications with Dexamethasone and Remdesivir
por: Grundmann, Alexander, et al.
Publicado: (2022)

Dexamethasone/remdesivir: Acute pancreatitis: case report
Publicado: (2022)

Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study
por: Kelton, Kari, et al.
Publicado: (2021)

Association and pharmacological synergism of the triple drug therapy baricitinib/remdesivir/rhACE2 for the management of COVID-19 infection
por: Vitiello, Antonio, et al.
Publicado: (2021)

Dexamethasone/propofol/remdesivir: Various toxicities: case report
Publicado: (2021)

Antibacterials/dexamethasone/remdesivir: Lack of efficacy: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Various toxicities: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy: case report
Publicado: (2022)

Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa
por: Jo, Youngji, et al.
Publicado: (2021)

REMDESIVIR-ASSOCIATED ASYMPTOMATIC BRADYCARDIA IN AN ICU PATIENT ON DEXAMETHASONE FOR COVID-19
por: HAIDER, MOBEEN, et al.
Publicado: (2022)

Treatment of severe alopecia areata with baricitinib
por: Olamiju, Brianna, et al.
Publicado: (2019)

Dexamethasone/remdesivir: Lack of efficacy and drug withdrawal: case report
Publicado: (2022)

A Case Report for Severe COVID-19 in a 9-Year-Old Child Treated with Remdesivir and Dexamethasone
por: Jo, Yoon Hee, et al.
Publicado: (2021)

Cerebellar Haemorrhage Leading to Sudden Cardiac Arrest
por: Agrawal, Ankit, et al.
Publicado: (2020)

A case report of COVID-19 in refractory myasthenia: Outcome with remdesivir and dexamethasone
por: Bhagavan, Sachin M., et al.
Publicado: (2021)

Baricitinib/dexamethasone: Myalgia and elevated creatine kinase following an off-label use: case report
Publicado: (2022)

Oral Bioactive Self-Nanoemulsifying Drug Delivery Systems of Remdesivir and Baricitinib: A Paradigmatic Case of Drug Repositioning for Cancer Management
por: Kazi, Mohsin, et al.
Publicado: (2023)

Metastatic Cutaneous Angiosarcoma: A Rare Entity
por: Blanco Jimenez, Javier, et al.
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Methaemoglobinaemia and off-label use: case report
Publicado: (2021)

Efficacy and Outcome of Remdesivir and Tocilizumab Combination Against Dexamethasone for the Treatment of Severe COVID-19: A Randomized Controlled Trial
por: Mohiuddin Chowdhury, Abu Taiub Mohammed, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ejkdm69qd1c7pmg48erpto2fbf